| ￥1200 | |
| A02538-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to Cytokeratin 5 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human Cytokeratin 5 |
| Species Reactivity | Human; Mouse |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||
|
|||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of Cytokeratin 5 expression in A431 cell lysate. »
| Target Background | Required for the formation of keratin intermediate filaments in the basal epidermis and maintenance of the skin barrier in response to mechanical stress. Regulates the recruitment of Langerhans cells to the epidermis, potentially by modulation of the abundance of macrophage chemotactic cytokines, macrophage inflammatory cytokines and CTNND1 localization in keratinocytes. |
| Synonyms | CK-5; CK5; Cytokeratin-5; DDD; EBS2; K2C5; K5; keratin 5; keratin 5 Keratin, type II; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
